Oversold stocks

Search documents
Top 3 Materials Stocks Which Could Rescue Your Portfolio This Quarter
Benzinga· 2025-08-14 13:15
The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies. Intrepid Potash Inc IPI Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and see how they compare. Read This Next: Photo via Shutterstock Loading... The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of ho ...
Down -9.16% in 4 Weeks, Here's Why Exelon (EXC) Looks Ripe for a Turnaround
ZACKS· 2025-05-15 14:36
Core Viewpoint - Exelon (EXC) has experienced significant selling pressure, declining 9.2% over the past four weeks, but is now positioned for a potential trend reversal as it is in oversold territory, supported by analyst expectations of better earnings than previously predicted [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is utilized to identify oversold stocks, with a reading below 30 indicating oversold conditions [2]. - EXC's current RSI reading is 28.78, suggesting that the heavy selling may be exhausting itself and a trend reversal could occur soon [5]. - The RSI helps investors identify potential entry opportunities when a stock is undervalued due to unwarranted selling pressure [3]. Group 2: Fundamental Indicators - There is a strong consensus among sell-side analysts that earnings estimates for EXC will improve, with a 1.3% increase in the consensus EPS estimate over the last 30 days [7]. - An upward trend in earnings estimate revisions typically correlates with price appreciation in the near term [7]. - EXC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate trends and EPS surprises, indicating a strong potential for a turnaround [8].
Allogene Therapeutics (ALLO) Loses -31.94% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ZACKS· 2025-05-15 14:36
Core Viewpoint - Allogene Therapeutics (ALLO) has experienced a significant decline of 31.9% over the past four weeks, but it is now in oversold territory, suggesting a potential turnaround as analysts expect better earnings than previously predicted [1]. Group 1: Stock Performance and Technical Indicators - ALLO's stock has been under heavy selling pressure, leading to an RSI reading of 25.87, indicating it is oversold [5]. - The Relative Strength Index (RSI) is a momentum oscillator that helps identify oversold conditions when the reading falls below 30 [2]. - Stocks oscillate between overbought and oversold states, and an oversold condition may present entry opportunities for investors anticipating a rebound [3]. Group 2: Analyst Sentiment and Earnings Estimates - There is a strong consensus among sell-side analysts to raise earnings estimates for ALLO, resulting in a 0.4% increase in the consensus EPS estimate over the last 30 days [7]. - An upward trend in earnings estimate revisions typically correlates with price appreciation in the near term [7]. - ALLO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate trends and EPS surprises, indicating a strong potential for a turnaround [8].
Down -22.15% in 4 Weeks, Here's Why Adherex Technologies (FENC) Looks Ripe for a Turnaround
ZACKS· 2025-04-10 14:35
Group 1 - Adherex Technologies Inc. (FENC) has experienced a significant downtrend, with a stock decline of 22.2% over the past four weeks, indicating strong selling pressure [1] - The stock is currently in oversold territory, as indicated by an RSI reading of 29.08, suggesting that the heavy selling may be exhausting itself and a rebound could be imminent [5] - There is a strong consensus among Wall Street analysts regarding FENC's ability to report better earnings than previously predicted, with a 124.3% increase in the consensus EPS estimate over the last 30 days [7] Group 2 - FENC holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a turnaround [8] - The upward trend in earnings estimate revisions typically correlates with price appreciation in the near term, further supporting the case for a potential rebound in FENC's stock price [7]
After Plunging -16.57% in 4 Weeks, Here's Why the Trend Might Reverse for Hyliion (HYLN)
ZACKS· 2025-03-31 14:36
Core Viewpoint - Hyliion Holdings Corp. (HYLN) has experienced significant selling pressure, resulting in a 16.6% decline over the past four weeks, but analysts anticipate better earnings than previously expected, indicating potential for recovery [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is utilized to identify oversold stocks, with a reading below 30 typically indicating oversold conditions [2]. - HYLN's current RSI reading is 29.79, suggesting that the stock may be nearing a reversal point due to the exhaustion of selling pressure [5]. Group 2: Fundamental Indicators - Analysts have raised earnings estimates for HYLN by 6.3% over the last 30 days, indicating a consensus among sell-side analysts that could lead to price appreciation [7]. - HYLN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which further supports the potential for a turnaround [8].
Here's Why Frontier Group (ULCC) is Poised for a Turnaround After Losing -31.11% in 4 Weeks
ZACKS· 2025-03-24 14:35
Group 1 - Frontier Group Holdings (ULCC) has experienced significant selling pressure, resulting in a stock price decline of 31.1% over the past four weeks, but it is now considered to be in oversold territory with potential for better earnings than previously predicted by analysts [1] - The Relative Strength Index (RSI) is a key technical indicator used to identify oversold stocks, with a reading below 30 typically indicating oversold conditions [2] - The RSI reading for ULCC is currently at 23.73, suggesting that the heavy selling may be exhausting itself and a price reversal could occur soon [5] Group 2 - Analysts have raised earnings estimates for ULCC by 0.4% over the last 30 days, indicating a positive trend that often leads to price appreciation [6] - ULCC holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further supporting the potential for a turnaround [7]
After Plunging -28.17% in 4 Weeks, Here's Why the Trend Might Reverse for Genasys (GNSS)
ZACKS· 2025-03-07 15:36
Group 1 - Genasys (GNSS) has experienced a significant decline of 28.2% over the past four weeks, but it is now in oversold territory, indicating a potential trend reversal [1] - The Relative Strength Index (RSI) for GNSS is currently at 27.66, suggesting that the heavy selling pressure may be exhausting itself [5] - There is a strong consensus among Wall Street analysts that GNSS will report better earnings than previously predicted, with a 17.1% increase in the consensus EPS estimate over the last 30 days [6] Group 2 - GNSS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a potential turnaround [7]
Down -31.1% in 4 Weeks, Here's Why You Should You Buy the Dip in Relay Therapeutics (RLAY)
ZACKS· 2025-03-05 15:36
Core Viewpoint - Relay Therapeutics, Inc. (RLAY) has experienced a significant decline of 31.1% over the past four weeks, but it is now in oversold territory, suggesting a potential turnaround due to improved earnings expectations from Wall Street analysts [1]. Group 1: Stock Performance and Technical Indicators - RLAY's stock has been under heavy selling pressure, leading to an RSI reading of 26.89, indicating it is oversold [5]. - The Relative Strength Index (RSI) is a momentum oscillator that helps identify oversold conditions when the reading falls below 30 [2]. - Stocks oscillate between overbought and oversold states, and an oversold condition may present entry opportunities for investors anticipating a rebound [3]. Group 2: Earnings Estimates and Analyst Consensus - There is a strong consensus among sell-side analysts that RLAY will report better earnings than previously predicted, with a 14.1% increase in the consensus EPS estimate over the last 30 days [6]. - RLAY holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a near-term turnaround [7].